Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2000 Mar-Apr;6(2):123–132. doi: 10.3201/eid0602.000204

Vaccines for mucosal immunity to combat emerging infectious diseases.

F W van Ginkel 1, H H Nguyen 1, J R McGhee 1
PMCID: PMC2640846  PMID: 10756145

Abstract

The mucosal immune system consists of molecules, cells, and organized lymphoid structures intended to provide immunity to pathogens that impinge upon mucosal surfaces. Mucosal infection by intracellular pathogens results in the induction of cell- mediated immunity, as manifested by CD4-positive (CD4 + ) T helper-type 1 cells, as well as CD8 + cytotoxic T-lymphocytes. These responses are normally accompanied by the synthesis of secretory immunoglobulin A (S-IgA) antibodies, which provide an important first line of defense against invasion of deeper tissues by these pathogens. New-generation live, attenuated viral vaccines, such as the cold-adapted, recombinant nasal influenza and oral rotavirus vaccines, optimize this form of mucosal immune protection. Despite these advances, new and reemerging infectious diseases are tipping the balance in favor of the parasite; continued mucosal vaccine development will be needed to effectively combat these new threats.

Full Text

The Full Text of this article is available as a PDF (222.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan C. H., Mendrick D. L., Trier J. S. Rat intestinal M cells contain acidic endosomal-lysosomal compartments and express class II major histocompatibility complex determinants. Gastroenterology. 1993 Mar;104(3):698–708. doi: 10.1016/0016-5085(93)91004-2. [DOI] [PubMed] [Google Scholar]
  2. Brière F., Bridon J. M., Chevet D., Souillet G., Bienvenu F., Guret C., Martinez-Valdez H., Banchereau J. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest. 1994 Jul;94(1):97–104. doi: 10.1172/JCI117354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carding S. R., Allan W., McMickle A., Doherty P. C. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J Exp Med. 1993 Feb 1;177(2):475–482. doi: 10.1084/jem.177.2.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Centers for Disease Control and Prevention (CDC) Control of infectious diseases. MMWR Morb Mortal Wkly Rep. 1999 Jul 30;48(29):621–629. [PubMed] [Google Scholar]
  5. Chisari F. V. Cytotoxic T cells and viral hepatitis. J Clin Invest. 1997 Apr 1;99(7):1472–1477. doi: 10.1172/JCI119308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cranage M. P., Whatmore A. M., Sharpe S. A., Cook N., Polyanskaya N., Leech S., Smith J. D., Rud E. W., Dennis M. J., Hall G. A. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology. 1997 Mar 3;229(1):143–154. doi: 10.1006/viro.1996.8419. [DOI] [PubMed] [Google Scholar]
  7. DeKruyff R. H., Rizzo L. V., Umetsu D. T. Induction of immunoglobulin synthesis by CD4+ T cell clones. Semin Immunol. 1993 Dec;5(6):421–430. doi: 10.1006/smim.1993.1048. [DOI] [PubMed] [Google Scholar]
  8. Ehrhardt R. O., Strober W., Harriman G. R. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation. J Immunol. 1992 Jun 15;148(12):3830–3836. [PubMed] [Google Scholar]
  9. Fehniger T. A., Herbein G., Yu H., Para M. I., Bernstein Z. P., O'Brien W. A., Caligiuri M. A. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol. 1998 Dec 1;161(11):6433–6438. [PubMed] [Google Scholar]
  10. Flynn K. J., Belz G. T., Altman J. D., Ahmed R., Woodland D. L., Doherty P. C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity. 1998 Jun;8(6):683–691. doi: 10.1016/s1074-7613(00)80573-7. [DOI] [PubMed] [Google Scholar]
  11. Fujihashi K., McGhee J. R., Lue C., Beagley K. W., Taga T., Hirano T., Kishimoto T., Mestecky J., Kiyono H. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest. 1991 Jul;88(1):248–252. doi: 10.1172/JCI115284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gallichan W. S., Rosenthal K. L. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med. 1996 Nov 1;184(5):1879–1890. doi: 10.1084/jem.184.5.1879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gallichan W. S., Rosenthal K. L. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med. 1996 Nov 1;184(5):1879–1890. doi: 10.1084/jem.184.5.1879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gruber W. C., Belshe R. B., King J. C., Treanor J. J., Piedra P. A., Wright P. F., Reed G. W., Anderson E., Newman F. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group. J Infect Dis. 1996 Jun;173(6):1313–1319. doi: 10.1093/infdis/173.6.1313. [DOI] [PubMed] [Google Scholar]
  15. Hou S., Doherty P. C. Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J Immunol. 1993 Jun 15;150(12):5494–5500. [PubMed] [Google Scholar]
  16. Kaetzel C. S., Robinson J. K., Lamm M. E. Epithelial transcytosis of monomeric IgA and IgG cross-linked through antigen to polymeric IgA. A role for monomeric antibodies in the mucosal immune system. J Immunol. 1994 Jan 1;152(1):72–76. [PubMed] [Google Scholar]
  17. Kernéis S., Bogdanova A., Kraehenbuhl J. P., Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 1997 Aug 15;277(5328):949–952. doi: 10.1126/science.277.5328.949. [DOI] [PubMed] [Google Scholar]
  18. Ksander B. R., Streilein J. W. Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites. J Immunol. 1990 Oct 1;145(7):2057–2063. [PubMed] [Google Scholar]
  19. Lebman D. A., Nomura D. Y., Coffman R. L., Lee F. D. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching. Proc Natl Acad Sci U S A. 1990 May;87(10):3962–3966. doi: 10.1073/pnas.87.10.3962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mazanec M. B., Kaetzel C. S., Lamm M. E., Fletcher D., Nedrud J. G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6901–6905. doi: 10.1073/pnas.89.15.6901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McIntyre T. M., Kehry M. R., Snapper C. M. Novel in vitro model for high-rate IgA class switching. J Immunol. 1995 Apr 1;154(7):3156–3161. [PubMed] [Google Scholar]
  22. Mostov K. E. Transepithelial transport of immunoglobulins. Annu Rev Immunol. 1994;12:63–84. doi: 10.1146/annurev.iy.12.040194.000431. [DOI] [PubMed] [Google Scholar]
  23. Musey L., Hu Y., Eckert L., Christensen M., Karchmer T., McElrath M. J. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med. 1997 Jan 20;185(2):293–303. doi: 10.1084/jem.185.2.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Neutra M. R., Frey A., Kraehenbuhl J. P. Epithelial M cells: gateways for mucosal infection and immunization. Cell. 1996 Aug 9;86(3):345–348. doi: 10.1016/s0092-8674(00)80106-3. [DOI] [PubMed] [Google Scholar]
  25. Novak M., Yamamoto M., Fujihashi K., Moldoveanu Z., Kiyono H., McGhee J. R., Mestecky J. Ig-secreting and interferon-gamma-producing cells in mice mucosally immunized with influenza virus. Adv Exp Med Biol. 1995;371B:1587–1590. [PubMed] [Google Scholar]
  26. Offit P. A., Cunningham S. L., Dudzik K. I. Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol. 1991 Mar;65(3):1318–1324. doi: 10.1128/jvi.65.3.1318-1324.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Offit P. A., Dudzik K. I. Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol. 1989 Aug;63(8):3507–3512. doi: 10.1128/jvi.63.8.3507-3512.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Offit P. A., Dudzik K. I. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J Virol. 1990 Dec;64(12):6325–6328. doi: 10.1128/jvi.64.12.6325-6328.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Quayle A. J., Coston W. M., Trocha A. K., Kalams S. A., Mayer K. H., Anderson D. J. Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals. J Immunol. 1998 Oct 15;161(8):4406–4410. [PubMed] [Google Scholar]
  30. Rizzo L. V., DeKruyff R. H., Umetsu D. T., Caspi R. R. Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo. Eur J Immunol. 1995 Mar;25(3):708–716. doi: 10.1002/eji.1830250312. [DOI] [PubMed] [Google Scholar]
  31. Spalding D. M., Williamson S. I., Koopman W. J., McGhee J. R. Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T cell mixtures. J Exp Med. 1984 Sep 1;160(3):941–946. doi: 10.1084/jem.160.3.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Taylor H. P., Dimmock N. J. Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med. 1985 Jan 1;161(1):198–209. doi: 10.1084/jem.161.1.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. VanCott J. L., Staats H. F., Pascual D. W., Roberts M., Chatfield S. N., Yamamoto M., Coste M., Carter P. B., Kiyono H., McGhee J. R. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol. 1996 Feb 15;156(4):1504–1514. [PubMed] [Google Scholar]
  34. Weiner D. B., Kennedy R. C. Genetic vaccines. Sci Am. 1999 Jul;281(1):50–57. doi: 10.1038/scientificamerican0799-50. [DOI] [PubMed] [Google Scholar]
  35. Wizemann T. M., Adamou J. E., Langermann S. Adhesins as targets for vaccine development. Emerg Infect Dis. 1999 May-Jun;5(3):395–403. doi: 10.3201/eid0503.990310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wolf J. L., Rubin D. H., Finberg R., Kauffman R. S., Sharpe A. H., Trier J. S., Fields B. N. Intestinal M cells: a pathway for entry of reovirus into the host. Science. 1981 Apr 24;212(4493):471–472. doi: 10.1126/science.6259737. [DOI] [PubMed] [Google Scholar]
  37. Xu-Amano J., Kiyono H., Jackson R. J., Staats H. F., Fujihashi K., Burrows P. D., Elson C. O., Pillai S., McGhee J. R. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med. 1993 Oct 1;178(4):1309–1320. doi: 10.1084/jem.178.4.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yang O. O., Kalams S. A., Trocha A., Cao H., Luster A., Johnson R. P., Walker B. D. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol. 1997 Apr;71(4):3120–3128. doi: 10.1128/jvi.71.4.3120-3128.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES